Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

NASDAQ:FRPT - Nasdaq - US3580391056 - Common Stock - Currency: USD

73.3  -4.27 (-5.5%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to FRPT. FRPT was compared to 89 industry peers in the Food Products industry. The financial health of FRPT is average, but there are quite some concerns on its profitability. FRPT is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year FRPT was profitable.
FRPT had a positive operating cash flow in the past year.
In the past 5 years FRPT reported 4 times negative net income.
Of the past 5 years FRPT 4 years had a positive operating cash flow.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.98%, FRPT is in line with its industry, outperforming 52.81% of the companies in the same industry.
FRPT's Return On Equity of 4.45% is in line compared to the rest of the industry. FRPT outperforms 47.19% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.10%, FRPT is in line with its industry, outperforming 41.57% of the companies in the same industry.
Industry RankSector Rank
ROA 2.98%
ROE 4.45%
ROIC 2.1%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

With a decent Profit Margin value of 4.81%, FRPT is doing good in the industry, outperforming 67.42% of the companies in the same industry.
FRPT's Operating Margin of 4.03% is in line compared to the rest of the industry. FRPT outperforms 53.93% of its industry peers.
The Gross Margin of FRPT (40.67%) is better than 92.13% of its industry peers.
FRPT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.03%
PM (TTM) 4.81%
GM 40.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRPT is destroying value.
Compared to 1 year ago, FRPT has more shares outstanding
Compared to 5 years ago, FRPT has more shares outstanding
Compared to 1 year ago, FRPT has an improved debt to assets ratio.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

FRPT has an Altman-Z score of 5.07. This indicates that FRPT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.07, FRPT belongs to the best of the industry, outperforming 86.52% of the companies in the same industry.
FRPT has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
FRPT has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: FRPT outperforms 57.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 5.07
ROIC/WACC0.25
WACC8.27%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

FRPT has a Current Ratio of 4.42. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
FRPT has a Current ratio of 4.42. This is amongst the best in the industry. FRPT outperforms 93.26% of its industry peers.
FRPT has a Quick Ratio of 3.60. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FRPT (3.60) is better than 96.63% of its industry peers.
Industry RankSector Rank
Current Ratio 4.42
Quick Ratio 3.6
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

8

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 232.39%, which is quite impressive.
Looking at the last year, FRPT shows a very strong growth in Revenue. The Revenue has grown by 27.17%.
Measured over the past years, FRPT shows a very strong growth in Revenue. The Revenue has been growing by 31.72% on average per year.
EPS 1Y (TTM)232.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%21.95%

3.2 Future

The Earnings Per Share is expected to grow by 41.37% on average over the next years. This is a very strong growth
FRPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.04% yearly.
EPS Next Y41.84%
EPS Next 2Y56.17%
EPS Next 3Y50.07%
EPS Next 5Y41.37%
Revenue Next Year21.04%
Revenue Next 2Y21.43%
Revenue Next 3Y20.26%
Revenue Next 5Y21.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

FRPT is valuated quite expensively with a Price/Earnings ratio of 77.98.
FRPT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of FRPT to the average of the S&P500 Index (28.29), we can say FRPT is valued expensively.
FRPT is valuated quite expensively with a Price/Forward Earnings ratio of 54.98.
The rest of the industry has a similar Price/Forward Earnings ratio as FRPT.
When comparing the Price/Forward Earnings ratio of FRPT to the average of the S&P500 Index (21.32), we can say FRPT is valued expensively.
Industry RankSector Rank
PE 77.98
Fwd PE 54.98
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRPT indicates a slightly more expensive valuation: FRPT is more expensive than 64.04% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.82
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
FRPT's earnings are expected to grow with 50.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.86
PEG (5Y)N/A
EPS Next 2Y56.17%
EPS Next 3Y50.07%

More info and screens

0

5. Dividend

5.1 Amount

FRPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESHPET INC

NASDAQ:FRPT (4/21/2025, 3:19:56 PM)

73.3

-4.27 (-5.5%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners109.13%
Inst Owner Change0.39%
Ins Owners1.71%
Ins Owner Change6.05%
Market Cap3.57B
Analysts82.4
Price Target147.79 (101.62%)
Short Float %10.04%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)55.94%
Min EPS beat(2)-8.85%
Max EPS beat(2)120.73%
EPS beat(4)3
Avg EPS beat(4)100.89%
Min EPS beat(4)-8.85%
Max EPS beat(4)254.36%
EPS beat(8)6
Avg EPS beat(8)112.3%
EPS beat(12)7
Avg EPS beat(12)57.22%
EPS beat(16)7
Avg EPS beat(16)-42.44%
Revenue beat(2)1
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)1.4%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.44%
Revenue beat(16)8
Avg Revenue beat(16)-0.5%
PT rev (1m)-6.59%
PT rev (3m)-14.47%
EPS NQ rev (1m)-53.8%
EPS NQ rev (3m)-72.78%
EPS NY rev (1m)-8.73%
EPS NY rev (3m)-5.74%
Revenue NQ rev (1m)-2.56%
Revenue NQ rev (3m)-5.7%
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE 77.98
Fwd PE 54.98
P/S 3.66
P/FCF N/A
P/OCF 23.15
P/B 3.38
P/tB 3.38
EV/EBITDA 34.82
EPS(TTM)0.94
EY1.28%
EPS(NY)1.33
Fwd EY1.82%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)3.17
OCFY4.32%
SpS20.02
BVpS21.66
TBVpS21.66
PEG (NY)1.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.98%
ROE 4.45%
ROCE 2.66%
ROIC 2.1%
ROICexc 2.57%
ROICexgc 2.57%
OM 4.03%
PM (TTM) 4.81%
GM 40.67%
FCFM N/A
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 3.71
Cap/Depr 254.15%
Cap/Sales 19.19%
Interest Coverage 3.87
Cash Conversion 136.66%
Profit Quality N/A
Current Ratio 4.42
Quick Ratio 3.6
Altman-Z 5.07
F-Score7
WACC8.27%
ROIC/WACC0.25
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)232.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
EPS Next Y41.84%
EPS Next 2Y56.17%
EPS Next 3Y50.07%
EPS Next 5Y41.37%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%21.95%
Revenue Next Year21.04%
Revenue Next 2Y21.43%
Revenue Next 3Y20.26%
Revenue Next 5Y21.04%
EBIT growth 1Y243.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year425.93%
EBIT Next 3Y109.75%
EBIT Next 5Y71.21%
FCF growth 1Y79.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.17%
OCF growth 3Y519.17%
OCF growth 5Y56.72%